article thumbnail

Radiologists can play key role in radiation therapy planning, but reimbursement an impediment

Radiology Business

Image interpretation can be one major source of variability, with some radiation oncologists forced to read MR, CT and other exams during the RT planning process.

Radiation 269
article thumbnail

ECR: PET/MRI highly effective for detecting prostate cancer

AuntMinnie

However, mpMRI misses about 10% of cases, typically in patients with lower-grade disease and in patients with cribriform pattern disease, a subtype much more likely to recur after surgery or radiation therapy, he noted. Interpretation accuracy is compared with biopsy results.

MRI 260
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Including radiologists in radiotherapy prep bolsters quality of care

Radiology Business

Many radiation oncologists are not formerly trained in imaging interpretation, and radiologists’ collaborative participation in care planning can help to catch errors, experts wrote recently.

article thumbnail

The Gold Standard in Medical Imaging: What ACR Accreditation Means to Us and Our Patients

Professional Radiology

The college represents thousands of radiologists, radiation oncologists, nuclear medicine physicians, and physicists. The institution is known as “the voice of radiology,” as they are at the forefront of innovation and therefore responsible for regulation and legislation around the field. Today, the College has 54 chapters.

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

This includes more streamlined processing, structured reporting, fast and high-quality contouring, advanced image fusion, dosimetry capabilities, easier IT integration, and remote access – helping to boost healthcare productivity and promote personalized patient care. There is also special focus on radiation therapy and Theranostics.

article thumbnail

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Imaging Technology

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Jani, MD, FASTRO, Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Ga.,

article thumbnail

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

Imaging Technology

A negative image does not rule out the presence of prostate cancer and a positive image does not confirm the presence of prostate cancer. POSLUMA use contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk for cancer.